Evidence map›Paper›PMID 41562015›Full record

ArticleIndian journal of urology : IJU : journal of the Urological Society of India

pH-dependent efficacy of nitrofurantoin against uropathogenic

Abhilash Mukhopadhyay, Deepak Kumar, Zinnu Rain, Sumit Rai, Shivendra Singh, Pradyot Prakash

Abstract read
In one paragraph

Article in Indian journal of urology : IJU : journal of the Urological Society of India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Abhilash MukhopadhyayDepartment of Microbiology, IMS, BHU, Varanasi, Uttar Pradesh, India.
Deepak KumarDepartment of Microbiology, IMS, BHU, Varanasi, Uttar Pradesh, India.
Zinnu RainDepartment of Microbiology, Bacterial Bio-film and Drug Resistance Research Laboratory, IMS, BHU, Varanasi, Uttar Pradesh, India.
Sumit RaiDepartment of Clinical Microbiology, All India Institute of Medical Sciences, Mangalgiri, Andhra Pradesh, India.
Shivendra SinghDepartment of Nephrology, IMS, BHU, Varanasi, Uttar Pradesh, India.
Pradyot PrakashDepartment of Microbiology, IMS, BHU, Varanasi, Uttar Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Uropathogenic Methods: A prospective study was conducted on 100 culture-confirmed UPEC isolates. Nitrofurantoin susceptibility was determined using the disk diffusion method, broth microdilution following Clinical and Laboratory Standards Institute (CLSI) guidelines, and the automated Vitek-2 system. The minimum bactericidal concentration (MBC) was evaluated in artificial urine at pH levels of 5.5 and 7.2, with estimated minimum inhibitory concentrations (MICs) derived as MBC ÷ 2. A subset of isolates underwent MIC validation in the pH-adjusted broth. Statistical analysis included Chi-square and Wilcoxon signed-rank tests. Results: Standard testing at pH 7.2 revealed an 85% susceptibility rate, concordant across both broth microdilution and Vitek-2. In contrast, acidic pH (5.5) markedly enhanced the activity of nitrofurantoin, reflected by significantly lower MBC and estimated MIC values compared to the neutral conditions ( Conclusion: Nitrofurantoin exhibits pronounced pH-dependent activity, with acidic environments enhancing its bactericidal efficacy against UPEC. Current susceptibility testing at neutral pH may underestimate the in vivo performance. Integrating urinary pH considerations into antimicrobial susceptibility testing and patient management could optimize the treatment outcomes and support personalized UTI therapy.

Identifiers

PMID41562015
PMCPMC12815434

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.